IRB Fees

The Human Research Protections unit in the Office of Research will charge Institutional Review Board (IRB) fees for new clinical research submissions that are partially or fully supported by industry sponsors, including chart review studies. 

The current IRB fee structure is:


IRB Review Fees apply to all clinical research involving human subjects that are funded in whole (including chart review studies) or in part by industry sponsors.  If UCI defers review to an independent IRB (e.g., Western IRB, Advarra), UCI IRB charges the one-time fee of $1,800 for administrative review and oversight. 


IRB Review Fees are not charged for the following:

  • Exempt research;
  • Modifications/ amendments to approved studies;
  • Unanticipated Problems


For additional information on what qualifies as “clinical research” for the purpose of IRB Fees, please see HRPP Policy# 6 and/ or the UCI IRB Review Fee Policy.


Human Subjects Research Budgets

Researchers need to account for applicable IRB Review Fees in their proposed budgets for industry-sponsored projects, as well as budgets for all subcontracts they expect to receive from such industry sponsors.


IRB Review Fee Collections Process

IRB fees are assessed once the research is approved by the IRB.  If the agreement / contract is finalized, the fees will be recharged to the study account. For recharges, e-mail notification is provided to the investigator and the department business office regarding the amount and date of each charge. 



If you have questions about the new IRB Fee structure contact Beverley Alberola, Interim Director of IRB Operations at 949-824-5746 or 


suggestions and comments